Literature DB >> 6136693

Incidence of multiple pregnancy after in-vitro fertilisation and embryo transfer.

J F Kerin, G M Warnes, P J Quinn, R Jeffrey, C Kirby, C D Matthews, R F Seamark, L W Cox.   

Abstract

7 multiple pregnancies occurred in a series of 20 pregnancies after oocyte recovery for in-vitro fertilisation and embryo transfer. After ovarian stimulation with clomiphene alone or with human menopausal gonadotropin, 102 laparoscopies were carried out in 62 women and the ongoing pregnancy rate beyond the first trimester was 17/102 laparoscopies (17%), including 5 sets of twins. 1 triplet and 1 twin pregnancy showed evidence of regression of two sacs and one sac, and both are progressing as singleton pregnancies at 16 and 34 weeks, respectively. 3 abortions occurred at 7, 8, and 9 weeks--a spontaneous abortion rate of 15%. The pregnancy and multiple pregnancy rates after stimulation with clomiphene alone or with human menopausal gonadotropin were comparable, but oocyte pickup based on a knowledge of the duration of the endogenous rise in luteinising hormone, rather than 36 h after administration of human chorionic gonadotropin, increased the pregnancy rate. As the quality and number of embryos transferred to the uterus increased, the risk of multiple pregnancy also rose. Consideration should therefore be given to restricting the number of embryos transferred to limit multiple pregnancies to twins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136693     DOI: 10.1016/s0140-6736(83)90569-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  In vitro fertilization and public policy: turning to the consumer.

Authors:  Andrea Bonnicksen
Journal:  Popul Res Policy Rev       Date:  1986

2.  Bilateral tubal ectopic pregnancy after in vitro fertilization and embryo transfer.

Authors:  J C Chang; Y C Lin; T T Sun
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-10

3.  In vitro fertilization and embryo transfer program, Department of Obstetrics and Gynecology, University of Adelaide at the Queen Elizabeth Hospital, Woodville, South Australia.

Authors:  J F Kerin; G M Warnes; P Quinn; C Kirby; R Jeffrey; C D Matthews; R F Seamark; K Texler; B Antonas; L W Cox
Journal:  J In Vitro Fert Embryo Transf       Date:  1984-03

4.  Multiple pregnancies in gonadotropin-stimulated cycles after human in vitro fertilization (IVF) and embryo replacement.

Authors:  L Mettler; H H Riedel; A Bonhoff; H W Michelmann
Journal:  Experientia       Date:  1985-12-15

5.  High incidence of preterm births and early losses in pregnancy after in vitro fertilisation. Australian in vitro fertilisation collaborative group.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-26

Review 6.  Drugs in the treatment of female infertility. Recent advances.

Authors:  M M Quigley
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

7.  Human in vitro fertilization employing individualized ovulation induction by human menopausal gonadotropins.

Authors:  N Laufer; A H Decherney; F P Haseltine; M L Polan; B C Tarlatzis; A M Dlugi; F Naftolin
Journal:  J In Vitro Fert Embryo Transf       Date:  1984-03

8.  Preliminary experience with a combination of clomiphene and variable dosages of menopausal gonadotropins for enhanced follicular recruitment.

Authors:  M M Quigley; C L Schmidt; P J Beauchamp; N F Maklad; A S Berkowitz; D P Wolf
Journal:  J In Vitro Fert Embryo Transf       Date:  1985-03

9.  Combined clomiphene citrate (CC) and human menopausal gonadotropins (hMG) in a fixed schedule for follicular recruitment during in vitro fertilization: effects on premature luteinizing hormone (LH) surges.

Authors:  J Blankstein; R L Collins; K A Easley; M K Gupta; M M Quigley
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-04

10.  Experience with the cryopreservation of human embryos using the mouse as a model to establish successful techniques.

Authors:  P Quinn; J F Kerin
Journal:  J In Vitro Fert Embryo Transf       Date:  1986-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.